• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与加州电鳐乙酰胆碱酯酶相互作用的抑制剂的1H NMR弛豫研究。

1H NMR relaxation investigation of inhibitors interacting with Torpedo californica acetylcholinesterase.

作者信息

Delfini M, Gianferri R, Dubbini V, Manetti C, Gaggelli E, Valensin G

机构信息

Department of Chemistry, University of Rome La Sapienza, P.le A.Moro, Rome, Italy.

出版信息

J Magn Reson. 2000 May;144(1):129-33. doi: 10.1006/jmre.2000.2031.

DOI:10.1006/jmre.2000.2031
PMID:10783282
Abstract

Two naphthyridines interacting with Torpedo californica acetylcholinesterase (AChE) were investigated. (1)H NMR spectra were recorded and nonselective, selective, and double-selective spin-lattice relaxation rates were measured. The enhancement of selective relaxation rates could be titrated by different ligand concentrations at constant AChE (yielding 0.22 and 1.53 mM for the dissociation constants) and was providing evidence of a diverse mode of interaction. The double-selective relaxation rates were used to evaluate the motional correlation times of bound ligands at 34.9 and 36.5 ns at 300 K. Selective relaxation rates of bound inhibitors could be interpreted also in terms of dipole-dipole interactions with protons in the enzyme active site.

摘要

研究了两种与加州电鳐乙酰胆碱酯酶(AChE)相互作用的萘啶。记录了(1)H NMR谱,并测量了非选择性、选择性和双选择性自旋晶格弛豫率。在恒定的AChE条件下,不同配体浓度可滴定选择性弛豫率的增强(解离常数分别为0.22和1.53 mM),这提供了多种相互作用模式的证据。双选择性弛豫率用于评估300 K时结合配体的运动相关时间,分别为34.9和36.5 ns。结合抑制剂的选择性弛豫率也可以用与酶活性位点中质子的偶极-偶极相互作用来解释。

相似文献

1
1H NMR relaxation investigation of inhibitors interacting with Torpedo californica acetylcholinesterase.与加州电鳐乙酰胆碱酯酶相互作用的抑制剂的1H NMR弛豫研究。
J Magn Reson. 2000 May;144(1):129-33. doi: 10.1006/jmre.2000.2031.
2
1H NMR relaxation investigation of acetylcholinesterase inhibitors from huperzine A and derivative.石杉碱甲及其衍生物乙酰胆碱酯酶抑制剂的1H NMR弛豫研究
Bioorg Med Chem Lett. 2004 Mar 22;14(6):1585-8. doi: 10.1016/j.bmcl.2003.12.055.
3
Interactions of Lycopodium alkaloids with acetylcholinesterase investigated by 1H NMR relaxation rate.通过¹H NMR弛豫速率研究石松生物碱与乙酰胆碱酯酶的相互作用。
Biophys Chem. 2007 Sep;129(2-3):212-7. doi: 10.1016/j.bpc.2007.05.020. Epub 2007 Jun 7.
4
Tacrine derivatives-acetylcholinesterase interaction: 1H NMR relaxation study.他克林衍生物与乙酰胆碱酯酶的相互作用:1H NMR弛豫研究。
Bioorg Chem. 2007 Jun;35(3):243-57. doi: 10.1016/j.bioorg.2007.01.001. Epub 2007 Feb 15.
5
Molecular docking studies of natural cholinesterase-inhibiting steroidal alkaloids from Sarcococca saligna.麻叶绣线菊中天然胆碱酯酶抑制甾体生物碱的分子对接研究。
J Med Chem. 2003 Nov 6;46(23):5087-90. doi: 10.1021/jm0309194.
6
An expedient synthesis, acetylcholinesterase inhibitory activity, and molecular modeling study of highly functionalized hexahydro-1,6-naphthyridines.高官能化六氢-1,6-萘啶的简便合成、乙酰胆碱酯酶抑制活性及分子模拟研究
Biomed Res Int. 2015;2015:965987. doi: 10.1155/2015/965987. Epub 2015 Jan 29.
7
Ester derivatives of annulated tetrahydroazocines: a new class of selective acetylcholinesterase inhibitors.稠环四氢氮杂辛的酯衍生物:一类新型的选择性乙酰胆碱酯酶抑制剂。
Bioorg Med Chem. 2006 Nov 1;14(21):7205-12. doi: 10.1016/j.bmc.2006.06.055. Epub 2006 Jul 14.
8
Conformational features of erythrocyte-bound chloroquine from double-selective 1H NMR relaxation.通过双选择性¹H NMR弛豫研究红细胞结合氯喹的构象特征。
Arch Biochem Biophys. 1994 Jan;308(1):48-51. doi: 10.1006/abbi.1994.1007.
9
1H and 19F NMR relaxation studies of fleroxacin with Micrococcus luteus.氟罗沙星与藤黄微球菌的1H和19F核磁共振弛豫研究。
J Pharm Biomed Anal. 2007 Apr 11;43(5):1595-601. doi: 10.1016/j.jpba.2006.12.018. Epub 2007 Jan 23.
10
Design, synthesis, and pharmacological profile of novel fused pyrazolo[4,3-d]pyridine and pyrazolo[3,4-b][1,8]naphthyridine isosteres: a new class of potent and selective acetylcholinesterase inhibitors.新型稠合吡唑并[4,3 - d]吡啶和吡唑并[3,4 - b][1,8]萘啶类似物的设计、合成及药理特性:一类新型强效选择性乙酰胆碱酯酶抑制剂
J Med Chem. 2003 Mar 27;46(7):1144-52. doi: 10.1021/jm020391n.